| |
| |
|
| Insider
Information: |
Wengel Kathryn E |
| Relationship: |
Director |
| City: |
New Brunswick |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
84,558 |
|
|
Indirect Shares
|
345 |
|
|
| Direct
Value |
$12,937,497 |
|
|
|
Indirect Value
|
$52,226 |
|
|
| Total
Shares |
84,903 |
|
|
| Total
Value |
$12,989,724 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
| Percentage
Gain/Loss : |
0.0%
|
 9.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Johnson & Johnson |
JNJ |
EVP, Chief TO and Risk... |
2024-02-13 |
82,266 |
2024-02-13 |
345 |
Premium* |
|
|
Laboratory Corp of America |
LH |
Director |
2024-02-07 |
2,292 |
2022-03-25 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-02-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,882 |
40,197 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-02-08 |
4 |
D |
$132.00 |
$313,236 |
D/D |
(2,373) |
37,824 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,722 |
44,546 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-02-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,102 |
45,648 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-02-11 |
4 |
D |
$131.94 |
$533,961 |
D/D |
(4,047) |
41,601 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-12-12 |
4 |
OE |
$62.62 |
$126,305 |
D/D |
2,017 |
51,736 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2019-12-12 |
4 |
S |
$141.07 |
$284,538 |
D/D |
(2,017) |
49,719 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2020-02-13 |
4 |
D |
$150.46 |
$1,070,072 |
D/D |
(7,112) |
58,420 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2020-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,809 |
65,532 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2020-09-02 |
4 |
OE |
$62.20 |
$1,027,323 |
D/D |
16,115 |
74,535 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2020-09-02 |
4 |
S |
$153.51 |
$2,473,938 |
D/D |
(16,115) |
58,420 |
0 |
% |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,362 |
68,837 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2021-02-12 |
4 |
D |
$165.55 |
$730,738 |
D/D |
(4,414) |
64,423 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,896 |
66,319 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-02-14 |
4 |
D |
$168.85 |
$117,351 |
D/D |
(695) |
65,624 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,386 |
76,010 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-02-15 |
4 |
D |
$165.89 |
$779,517 |
D/D |
(4,699) |
71,311 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2022-03-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
603 |
603 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-11-09 |
4 |
OE |
$72.54 |
$1,190,381 |
D/D |
16,410 |
87,721 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief GSC Officer |
• • – |
2022-11-09 |
4 |
S |
$173.42 |
$2,845,773 |
D/D |
(16,410) |
71,311 |
0 |
% |
|
| JNJ |
Johnson & Johnson |
EVP, Chief TO and Risk Officer |
• • – |
2023-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,807 |
73,118 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief TO and Risk Officer |
• • – |
2023-02-10 |
4 |
D |
$162.08 |
$108,107 |
D/D |
(667) |
72,451 |
0 |
- |
|
| LH |
Laboratory Corp of Americ... |
Director |
• • – |
2023-02-11 |
4 |
OE |
$0.00 |
$0 |
D/D |
742 |
1,345 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief TO and Risk Officer |
• • – |
2023-02-13 |
4 |
D |
$162.01 |
$792,391 |
D/D |
(4,891) |
78,399 |
0 |
- |
|
| JNJ |
Johnson & Johnson |
EVP, Chief TO and Risk Officer |
• • – |
2023-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
10,839 |
83,290 |
0 |
- |
|
36 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
